can i still get compound tirzepatide Compounding pharmacies resume making as FDA reconsiders shortage Compounded Tirzepatide – BloomMD
Description
In Q1 2026, the pharma giant reported $19.8B in revenue, up 56% YoY, blowing past expectations while raising full-year guidance to $82B$85B
While our current treatments have shown significant therapeutic benefits, there still appear to be some patients who, despite aggressive therapy, good adherence, and inhaler technique, continue to have exacerbations
Yes, you read the feedback correctly
Looking for the best electrolytes for GLP-1 users
No, a patient currently on semaglutide 2mg should not start tirzepatide at 10mgthe FDA-approved starting dose is 2.5mg weekly, followed by gradual titration...
